300 related articles for article (PubMed ID: 36140405)
1. Dipeptidyl Peptidase 4 (DPP4) as A Novel Adipokine: Role in Metabolism and Fat Homeostasis.
Barchetta I; Cimini FA; Dule S; Cavallo MG
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140405
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.
Lamers D; Famulla S; Wronkowitz N; Hartwig S; Lehr S; Ouwens DM; Eckardt K; Kaufman JM; Ryden M; Müller S; Hanisch FG; Ruige J; Arner P; Sell H; Eckel J
Diabetes; 2011 Jul; 60(7):1917-25. PubMed ID: 21593202
[TBL] [Abstract][Full Text] [Related]
3. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
Mulvihill EE
Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
[TBL] [Abstract][Full Text] [Related]
4. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity.
Romacho T; Sell H; Indrakusuma I; Roehrborn D; Castañeda TR; Jelenik T; Markgraf D; Hartwig S; Weiss J; Al-Hasani H; Roden M; Eckel J
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E590-E599. PubMed ID: 31891536
[TBL] [Abstract][Full Text] [Related]
5. Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis.
Mulvihill EE; Varin EM; Gladanac B; Campbell JE; Ussher JR; Baggio LL; Yusta B; Ayala J; Burmeister MA; Matthews D; Bang KWA; Ayala JE; Drucker DJ
Cell Metab; 2017 Jan; 25(1):152-165. PubMed ID: 27839908
[TBL] [Abstract][Full Text] [Related]
6. Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro.
Sell H; Blüher M; Klöting N; Schlich R; Willems M; Ruppe F; Knoefel WT; Dietrich A; Fielding BA; Arner P; Frayn KN; Eckel J
Diabetes Care; 2013 Dec; 36(12):4083-90. PubMed ID: 24130353
[TBL] [Abstract][Full Text] [Related]
7. DPP4 in Diabetes.
Röhrborn D; Wronkowitz N; Eckel J
Front Immunol; 2015; 6():386. PubMed ID: 26284071
[TBL] [Abstract][Full Text] [Related]
8. Circulating Levels of Soluble Dipeptidyl Peptidase-4 Are Dissociated from Inflammation and Induced by Enzymatic DPP4 Inhibition.
Varin EM; Mulvihill EE; Beaudry JL; Pujadas G; Fuchs S; Tanti JF; Fazio S; Kaur K; Cao X; Baggio LL; Matthews D; Campbell JE; Drucker DJ
Cell Metab; 2019 Feb; 29(2):320-334.e5. PubMed ID: 30393019
[TBL] [Abstract][Full Text] [Related]
9. Reduced DPP4 activity improves insulin signaling in primary human adipocytes.
Röhrborn D; Brückner J; Sell H; Eckel J
Biochem Biophys Res Commun; 2016 Mar; 471(3):348-54. PubMed ID: 26872429
[TBL] [Abstract][Full Text] [Related]
10. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus.
Barchetta I; Ciccarelli G; Barone E; Cimini FA; Ceccarelli V; Bertoccini L; Sentinelli F; Tramutola A; Del Ben M; Angelico F; Baroni MG; Lenzi A; Cavallo MG
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1087-1094. PubMed ID: 31431395
[TBL] [Abstract][Full Text] [Related]
11. Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice.
Chae YN; Kim TH; Kim MK; Shin CY; Jung IH; Sohn YS; Son MH
PLoS One; 2015; 10(12):e0144064. PubMed ID: 26633898
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?
Silva Júnior WS; Godoy-Matos AF; Kraemer-Aguiar LG
Biomed Res Int; 2015; 2015():816164. PubMed ID: 26146634
[TBL] [Abstract][Full Text] [Related]
13. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease.
Zhong J; Rao X; Rajagopalan S
Atherosclerosis; 2013 Feb; 226(2):305-14. PubMed ID: 23083681
[TBL] [Abstract][Full Text] [Related]
14. Computer-Aided Screening of Phytoconstituents from
Sajal H; Patil SM; Raj R; Shbeer AM; Ageel M; Ramu R
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014373
[TBL] [Abstract][Full Text] [Related]
15. Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4.
Ohara-Nemoto Y; Nakasato M; Shimoyama Y; Baba TT; Kobayakawa T; Ono T; Yaegashi T; Kimura S; Nemoto TK
Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28630069
[TBL] [Abstract][Full Text] [Related]
16. Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism.
Miyazaki M; Kato M; Tanaka K; Tanaka M; Kohjima M; Nakamura K; Enjoji M; Nakamuta M; Kotoh K; Takayanagi R
Mol Med Rep; 2012 Mar; 5(3):729-33. PubMed ID: 22179204
[TBL] [Abstract][Full Text] [Related]
17. High circulating plasma dipeptidyl peptidase- 4 levels in non-obese Asian Indians with type 2 diabetes correlate with fasting insulin and LDL-C levels, triceps skinfolds, total intra-abdominal adipose tissue volume and presence of diabetes: a case-control study.
Anoop S; Misra A; Bhatt SP; Gulati S; Pandey RM; Mahajan H
BMJ Open Diabetes Res Care; 2017; 5(1):e000393. PubMed ID: 29188065
[TBL] [Abstract][Full Text] [Related]
18. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.
Zhong J; Maiseyeu A; Davis SN; Rajagopalan S
Circ Res; 2015 Apr; 116(8):1491-504. PubMed ID: 25858071
[TBL] [Abstract][Full Text] [Related]
19. Influence of Dipeptidyl Peptidase-4 (DPP4) on Mesenchymal Stem-Cell (MSC) Biology: Implications for Regenerative Medicine - Review.
Torrecillas-Baena B; Gálvez-Moreno MÁ; Quesada-Gómez JM; Dorado G; Casado-Díaz A
Stem Cell Rev Rep; 2022 Jan; 18(1):56-76. PubMed ID: 34677817
[TBL] [Abstract][Full Text] [Related]
20. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
Klemann C; Wagner L; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
